University of Edinburgh develops cell therapy for liver disease
In the MATCH clinical trial, 26 patients received macrophage therapy while 24 had standard care.
Drug Manufacturers
Pharma’s manufacturing reconfigurations provide CDMOs with expansion opportunities
GSK and SBP Group team up to advance bepirovirsen launch in China
Aligos and Xiamen Amoytop sign deal for HBV therapy
Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design
CordenPharma leases space at Flatiron Park for peptides development
Europe’s pharma trade with the US remains critical despite tariff turmoil
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
